RNF126P1

Across TCGA pan-cancer cohorts, RNF126P1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RNF126P1 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNF126P1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNF126P1 expression acts as an unfavorable survival marker.

BLCA, UCEC, and COAD are the cancer types where RNF126P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.139	0.626	.010	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
COAD	DFS	Median	All	0.172	0.696	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNF126P1–BLCA (DFS)

Open the BLCA breakdown →